Completed
Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment
NCT03446001
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Xenoscience Phoenix, Arizona, United States
- Arizona Research Center Phoenix, Arizona, United States
- Imaging Endpoints Research Scottsdale, Arizona, United States
- Atria Clinical Research Little Rock, Arkansas, United States